Maternal immunisation in developing countries

Area of Science:

• Public Health
• Infectious Disease Prevention
• Maternal and Child Health

Background:

• Neonatal and early infant mortality remains high in developing countries, with infections likely causing at least half of these deaths.
• Maternal immunisation is a viable strategy to protect infants, leveraging existing antenatal care systems and public acceptance demonstrated by tetanus vaccination programs.
• Co-infections like HIV and malaria in pregnant women may impact vaccine efficacy, necessitating further research.

Purpose of the Study:

• To explore the potential of maternal immunisation in preventing neonatal and early infant deaths in developing countries.
• To investigate the feasibility and acceptance of maternal immunisation delivery systems.
• To advocate for trials of specific vaccines, such as pneumococcal vaccines, for maternal use.

Main Methods:

• Review of existing data on causes of infant mortality in developing countries.
• Analysis of the effectiveness of current maternal immunisation programs (e.g., tetanus).
• Consideration of factors affecting vaccine efficacy, including co-infections.

Main Results:

• Maternal immunisation is a potentially effective and accepted method for preventing infant mortality.
• Existing antenatal care infrastructure can support maternal vaccination programs.
• Pneumococcal infections are a significant cause of early infant mortality, occurring before infant vaccination can provide protection.

Conclusions:

• Maternal immunisation holds significant potential for reducing preventable infant deaths in developing regions.
• Further research and trials are warranted to evaluate specific vaccines, like pneumococcal conjugate vaccines, for maternal administration.
• Addressing challenges posed by co-infections is crucial for optimizing maternal immunisation strategies.